Literature DB >> 22331086

[Rare differential diagnosis in a 40-year old patient with sleep apnea syndrome].

A Mandecka1, C Kloos, W Hunger-Battefeld, A Hochstetter, M Gajda, G Wolf, U A Müller.   

Abstract

Respiratory disorders are common and important complications in acromegaly. The prevalence of sleep apnea syndrome (SAS) in this group of patients is high (20%-50%). Consequences of SAS are serious and associated with increased morbidity and mortality, mainly as a result of cardiovascular complications. The symptoms of sleep apnea are often reversible with treatment. We report on an acromegaly patient presenting with excessive snoring and severe headaches caused by sleep apnea.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22331086     DOI: 10.1007/s00106-011-2310-3

Source DB:  PubMed          Journal:  HNO        ISSN: 0017-6192            Impact factor:   1.284


  10 in total

1.  The German Acromegaly Registry: description of the database and initial results.

Authors:  M Reincke; S Petersenn; M Buchfelder; B Gerbert; G Skrobek-Engel; H Franz; R Lohmann; H-J Quabbe
Journal:  Exp Clin Endocrinol Diabetes       Date:  2006-10       Impact factor: 2.949

2.  Bromocriptine treatment over 12 years in acromegaly: effect on growth hormone and prolactin secretion.

Authors:  H Rau; P H Althoff; K Schmidt; K H Usadel
Journal:  Acta Endocrinol (Copenh)       Date:  1992-03

3.  Prevalence of sleep apnea and metabolic abnormalities in patients with acromegaly and analysis of cephalometric parameters by magnetic resonance imaging.

Authors:  Flávia R B van Haute; Giselle F Taboada; Lívia L Corrêa; Giovanna A B Lima; Rosita Fontes; Anna Patricia Riello; Michele Dominici; Mônica R Gadelha
Journal:  Eur J Endocrinol       Date:  2008-04       Impact factor: 6.664

4.  Acromegaly, colonic polyps and carcinoma.

Authors:  P J Jenkins; P D Fairclough; T Richards; D G Lowe; J Monson; A Grossman; J A Wass; M Besser
Journal:  Clin Endocrinol (Oxf)       Date:  1997-07       Impact factor: 3.478

Review 5.  Medical therapy for acromegaly.

Authors:  C B Newman
Journal:  Endocrinol Metab Clin North Am       Date:  1999-03       Impact factor: 4.741

6.  Effect of transsphenoidal surgery on sleep apnoea in acromegaly.

Authors:  Lisa Sze; Christoph Schmid; Konrad E Bloch; René Bernays; Michael Brändle
Journal:  Eur J Endocrinol       Date:  2007-03       Impact factor: 6.664

7.  A retrospective hormonal and immunohistochemical evaluation of 47 acromegalic patients: prognostic value of preoperative plasma prolactin.

Authors:  L De Marinis; P Zuppi; D Valle; A Mancini; A Bianchi; L Lauriola; P Pasquini; C Anile; G Maira; A Giustina
Journal:  Horm Metab Res       Date:  2002-03       Impact factor: 2.936

Review 8.  Acromegaly.

Authors:  J D Nabarro
Journal:  Clin Endocrinol (Oxf)       Date:  1987-04       Impact factor: 3.478

9.  Sleep apnoea syndrome is highly prevalent in acromegaly and only partially reversible after biochemical control of the disease.

Authors:  Maria Vittoria Davi'; Luca Dalle Carbonare; Andrea Giustina; Marcello Ferrari; Anna Frigo; Vincenzo Lo Cascio; Giuseppe Francia
Journal:  Eur J Endocrinol       Date:  2008-09-02       Impact factor: 6.664

Review 10.  Endocrine aspects of obstructive sleep apnea.

Authors:  Pierre Attal; Philippe Chanson
Journal:  J Clin Endocrinol Metab       Date:  2010-01-08       Impact factor: 5.958

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.